Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-04

Clinical Trial Update: The Efficacy and the Safety of Vitamin D3 30,000 IU for Loading Dose Schedules [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating efficacy and safety of a high-dose vitamin D3 loading schedule (30,000 IU) for vitamin D deficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Semmelweis University | Conditions: Vitamin D Deficiency | Phase 3 | Status: COMPLETED